FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Sanders, Cummings Launch Congressional Investigation into Marathon’s $89,000 Drug February 13, 2017 FDA Cites Indian Drugmaker for Sterility, Testing Issues January 1, 2018 Study Suggests Covis Pharma’s Preterm Birth Drug Carries Cancer Risk November 9, 2021
